1. Hood DC, Kardon RH. A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res. 2007; 26:688–710.
Article
2. Quigley HA, Addicks EM, Green WR. Optic nerve damage in hu-man glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982; 100:135–46.
3. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989; 107:453–64.
Article
4. Anderson RS. The psychophysics of glaucoma: improving the structure/function relationship. Prog Retin Eye Res. 2006; 25:79–97.
Article
5. . . Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000; 41:741–8.
6. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994; (3 Suppl 1):S32–44.
Article
7. Johnson CA. The Glenn A. Fry Award Lecture. Early losses of vis-ual function in glaucoma. Optom Vis Sci. 1995; 72:359–70.
Article
8. Jung KI, Park HY, Park CK. Characteristics of optic disc morphol-ogy in glaucoma patients with parafoveal scotoma compared to pe-ripheral scotoma. Invest Ophthalmol Vis Sci. 2012; 53:4813–20.
Article
9. Traynis I, De Moraes CG, Raza AS. . Prevalence and nature of early glaucomatous defects in the central 10° of the visual field. JAMA Ophthalmol. 2014; 132:291–7.
Article
10. Shin HY, Park HY, Jung KI. . Glaucoma diagnostic ability of ganglion cell-inner plexiform layer thickness differs according to the location of visual field loss. Ophthalmology. 2014; 121:93–9.
Article
11. Park HY, Hwang BE, Shin HY, Park CK. Clinical clues to predict the presence of parafoveal scotoma on humphrey 10-2 visual field using a humphrey 24-2 visual field. Am J Ophthalmol. 2016; 161:150–9.
Article
12. Park SC, Kung Y, Su D. . Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis. Ophthalmology. 2013; 120:1546–50.
13. Hangai M, Ikeda HO, Akagi T, Yoshimura N. Paracentral scotoma in glaucoma detected by 10-2 but not by 24-2 perimetry. Jpn J Ophthalmol. 2014; 58:188–96.
Article
14. Brusini P, Salvetat ML, Zeppieri M, Parisi L. Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test. J Glaucoma. 2006; 15:77–83.
Article
15. Medeiros FA, Sample PA, Zangwill LM. . A statistical ap-proach to the evaluation of covariate effects on the receiver operat-ing characteristic curves of diagnostic tests in glaucoma. Invest Ophthalmol Vis Sci. 2006; 47:2520–7.
Article
16. Racette L, Medeiros FA, Zangwill LM. . Diagnostic accuracy of the Matrix 24-2 and original N-30 frequency-doubling technol-ogy tests compared with standard automated perimetry. Invest Ophthalmol Vis Sci. 2008; 49:954–60.
Article
17. Jung KI, Kang MK, Choi JA. . Structure-function relationship in glaucoma patients with parafoveal versus peripheral nasal scotoma. Invest Ophthalmol Vis Sci. 2016; 57:420–8.
Article
18. Park SC, De Moraes CG, Teng CC. . Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology. 2011; 118:1782–9.
Article